Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma

• Jennifer E. Yeh, MD, PhD,
• Marilyn T. Wan, MBChB, MPH,
• Allireza Alloo, MD,
• Nageatte Ibrahim, MD,
• Patrick A. Ott, MD, PhD,
• Elizabeth I. Buchbinder, MD,
• Jennifer Y. Lin, MD

Affiliations

Jennifer E. Yeh, MD, PhD

Department of Dermatology, Stanford University School of Medicine, Redwood City, California

Marilyn T. Wan, MBChB, MPH

Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra Northwell, New Hyde Park, New York

Allireza Alloo, MD

Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra Northwell, New Hyde Park, New York

Nageatte Ibrahim, MD

Department of Medical Oncology, Melanoma Center, Dana Farber Cancer Institute, Boston, Massachusetts

Patrick A. Ott, MD, PhD

Department of Medical Oncology, Melanoma Center, Dana Farber Cancer Institute, Boston, Massachusetts

Elizabeth I. Buchbinder, MD

Department of Medical Oncology, Melanoma Center, Dana Farber Cancer Institute, Boston, Massachusetts

Jennifer Y. Lin, MD

Department of Medical Oncology, Melanoma Center, Dana Farber Cancer Institute, Boston, Massachusetts; Department of Dermatology, Brigham & Women’s Hospital, Boston, Massachusetts; Correspondence to: Jennifer Y. Lin, MD, Department of Dermatology, Brigham and Women’s Hospital, Emmanuel College, Alumnae Hall, 41 Ave Louis Pasteur, Boston, MA 02115.